key: cord-0016443-3wg9he3u
authors: Yutuc, Eylan; Dickson, Alison L.; Pacciarini, Manuela; Griffiths, Lauren; Baker, Paul R.S.; Connell, Lisa; Öhman, Anders; Forsgren, Lars; Trupp, Miles; Vilarinho, Sílvia; Khalil, Youssef; Clayton, Peter T.; Sari, Sinan; Dalgic, Buket; Höflinger, Philip; Schöls, Ludger; Griffiths, William J.; Wang, Yuqin
title: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
date: 2021-04-15
journal: Anal Chim Acta
DOI: 10.1016/j.aca.2021.338259
sha: cf2a04d5938a97cf0d66ac6dc57c156e8f590984
doc_id: 16443
cord_uid: 3wg9he3u

Both plasma and cerebrospinal fluid (CSF) are rich in cholesterol and its metabolites. Here we describe in detail a methodology for the identification and quantification of multiple sterols including oxysterols and sterol-acids found in these fluids. The method is translatable to any laboratory with access to liquid chromatography – tandem mass spectrometry. The method exploits isotope-dilution mass spectrometry for absolute quantification of target metabolites. The method is applicable for semi-quantification of other sterols for which isotope labelled surrogates are not available and approximate quantification of partially identified sterols. Values are reported for non-esterified sterols in the absence of saponification and total sterols following saponification. In this way absolute quantification data is reported for 17 sterols in the NIST SRM 1950 plasma along with semi-quantitative data for 8 additional sterols and approximate quantification for one further sterol. In a pooled (CSF) sample used for internal quality control, absolute quantification was performed on 10 sterols, semi-quantification on 9 sterols and approximate quantification on a further three partially identified sterols. The value of the method is illustrated by confirming the sterol phenotype of a patient suffering from ACOX2 deficiency, a rare disorder of bile acid biosynthesis, and in a plasma sample from a patient suffering from cerebrotendinous xanthomatosis, where cholesterol 27-hydroxylase is deficient.

Supplemental Methods Flowchart 1. Schematic illustration of sample preparation. Single-phase liquid extraction is performed into ethanol containing internal standards in the presence or absence of 0.35 M KOH. Figure S4L . ]25-D3 (543.4588 ± 5 ppm, lower panel); (B) 3βH-Δ 5 -BA (511.3691 ± 5 ppm); (C) 3β,7β-diH-Δ 5 -BA and 3α,7α-diH-Δ 5 -BA + 7αH,3O-Δ 4 -BA (527.3640 ± 5 ppm, upper panel); 7αH,3O-Δ 4 -BA (522.3326 ± 5 ppm, lower panel,); (D) 3β-HCA + 3O-CA (553.4161 ± 5 ppm, upper panel,); 3O-CA (548.3847 ± 5 ppm, lower panel); (E -H) 3β,7α,24-triHCA + 7α,24-diH,3O-CA, 3β,7α,25-triHCA + 7α,25-diH,3O-CA and 3β,7α,12α-triHCA + 7α,12α-diH,3O-CA (585.4059 ± 5 ppm, upper panels); (E) Lower panel, 7α,24-diH,3O-CA, 7α,25-diH,3O-CA and 7α,12α-diH,3O-CA (580.3739 ± 5 ppm); (F -H) Lower panels show MRM chromatograms targeting (F) 3β,7α,24-triHCA + 7α,24-diH,3O-CA; (G) 3β,7α,25-triHCA + 7α,25-diH,3O-CA; (H) 3β,7α,12α-triHCA and 7α,12α-diH,3O-CA. Authentic standards are not available for 3β,7α,12α-triHCA and 7α,12α-diH,3O-CA. Coloured dashed lines indicate the coincidence of oxysterols between chromatograms. MS 3 spectra are presented in Figures S11 & S12. ] + ) spectra of (A) 3β,7α,24-triHCA + 7α,24-diH,3O-CA; (B) 3β,7α,25-triHCA + 7α,25-diH,3O-CA; (C) 3β,7α,12α-triHCA + 7α,12α-diH,3O-CA (no authentic standard). The formation of key fragment ions is illustrated in Figure S4P -R. Figure S13 . MS 3 fragmentation of GP-derivatised oxysterols in plasma. MS 3 spectra of the postulated structures (A) 3β, 25, (no authentic standards available); (B) 3β,27-diHCA or 3β,27,x-trihydroxycholest-5-en-y-one (no authentic standards available); (C) 3β,x-diHCA or 3β,x,y-trihydroxycholest-5-en-z-one (no authentic standards available); (D) 3β, 22, ; (E) 3β, 22-dihydroxycholest-5en-24-one or 3β,20-dihydroxycholest-5-en-22-one (no authentic standard) ; (F) 7α,x-diH,3O-CA (no authentic standard). The more likely structures are given in italics. The formation of key fragment ions is illustrated in Figure S4S -V. Figure S14 . MS 3 fragmentation of GP-derivatised of trihydroxycholestenoic (triHCA) and dihydroxy-3oxocholestenoic acids (diH,3O-CA) in CSF. MS 3 ([M] + [M-Py] + ) spectra of (A) 3β,7α,24-triHCA + 7α,24-diH,3O-CA; (B) 3β,7α,25-triHCA + 7α,25-diH,3O-CA; (C) 3β,7α,12α-triHCA + 7α,12α-diH,3O-CA (no authentic standard) and (D) 3β,7α,x-triHCA + 7α,x-diH,3O-CA. The formation of key fragment ions is illustrated in Figure S4P -R. Table S1 . Systematic and common names of sterols including oxysterols and sterol-acids identified or partially identified in the current study. Supplier of reference standards are indicated when available. 

EY_191014_100uL-NIST-QC_100uL-OxySpla... 

Cambridge Pooled CSF (2019) + 20ul OxysterolSPLASH + 1ng 22S-HCO-D7 + 0.2ug Chol-D7(certified) EY_191029_100uL-Cambridge-CSF-pool_20uL-OxySPLASH_r2_NON-HYDRO_+1ng-22S-HCO-d7_Fr1A=GPd5_Fr1B=GPd0_s2_neat_07 #845 RT: 3.76 AV: 1 NL: 2.89E2 F: ITMS + c ESI Full ms3 585gradient) 3β,7α